相关实验视频
Updated: Jul 13, 2025

13:25
Acute Kidney Injury Model Induced by Cisplatin in Adult Zebrafish
Published on: May 15, 2021
5.8K
实施万科米辛方案减少脏毒性的影响:一项比较性研究
Graziella Gasparotto Baiocco1, Stephanie Greiner2, Mário Borges Rosa3
1Programa de Pós-Graduação em Ciências da Saúde, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Brazil.
Frontiers in pharmacology
|October 16, 2023
概括
实施万科米辛的管理方案显著降低了患者急性损伤 (AKI) 的发生率. 该协议确保了更安全的万科米辛剂量,最大限度地降低了毒性,并改善了临床结果.
科学领域:
- 药理学和治疗学 药理学和治疗学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 传染性疾病 传染性疾病
背景情况:
- 范科米辛对于治疗格拉姆阳性感染至关重要,但具有毒性风险.
- 有效使用万科米需要仔细的管理和剂量监测,以平衡有效性和安全性.
- 了解香草素对临床结果的影响,包括急性损伤 (AKI),至关重要.
研究的目的:
- 评估在实施机构协议之前和之后接受万科米辛的患者中AKI的发病率.
- 评估一种标准化的万科米辛 (vancomycin) 给药方案对患者安全和临床结果的影响.
主要方法:
- 一项横截面研究分析了422名接受Vancomycin的患者的电子病历.
- 患者被分为两个队列:2016年 (协议前) 和2018年 (协议后).
- 使用后勤回归和ROC曲线分析来预测AKI并评估模型性能 (AUC 0.764).
主要成果:
- 协议后队列 (2018年) 显示,与协议前队列 (38.4%) 相比,AKI发病率 (20.9%) 显著减少 (p < 0.001).
- 协议后的患者年龄较大,基线水平较高的肌素,ICU入院次数增加和血管压缩剂使用.
- 后勤回归模型证明了可接受的歧视来预测AKI.
结论:
- 实行机构范菌素管理方案显著降低了AKI发病率.
- 该协议确保了适当的治疗剂量,从而减少了毒性等不良事件.
- 该协议证明了对改善患者临床结果的显著,具有成本效益的影响.
相关概念视频
Acute Kidney Injury IV: Diagnostic Studies and Prevention
20
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
20
Renal Failure: Dose Adjustments
98
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
98
Acute Kidney Injury V: Interprofessional Care
11
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
11
Renal Drug Excretion: Overview
167
As primary excretory organs, the kidneys maintain homeostasis by removing waste substances from the bloodstream. They comprise over a million units called nephrons, which serve as the kidney's functional units.
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...
167
Renal Drug Excretion: Tubular Secretion
197
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
197
Renal Drug Excretion: Tubular Reabsorption
194
Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...
194

